Laurie Beall
Acute Care · Dallas, TXNPI 1871368050
Payments from drug & device makers
Across 107 payments — averaging $27.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$540
- Pfizer$259
- Kestra Medical Technology Services, Inc.$247
- Abiomed$216
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$204
- Actelion Pharmaceuticals US, Inc.$174
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,943100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 25 | $540 |
| Pfizer | 13 | $259 |
| Kestra Medical Technology Services, Inc. | 9 | $247 |
| Abiomed | 5 | $216 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $204 |
| Actelion Pharmaceuticals US, Inc. | 6 | $174 |
| Bayer | 7 | $170 |
| Atricure, Inc. | 1 | $156 |
| La Jolla Pharmaceutical Company | 1 | $121 |
| AbbVie | 1 | $114 |
| Novo Nordisk | 4 | $109 |
| Alnylam Pharmaceuticals Inc. | 5 | $103 |
| Boehringer Ingelheim | 4 | $92 |
| Heartflow, Inc. | 1 | $88 |
| Amgen | 5 | $80 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $66 |
| Bridgebio Pharma, Inc. | 2 | $59 |
| Recor Medical Inc | 3 | $45 |
| AstraZeneca | 2 | $34 |
| Medtronic | 1 | $29 |
| GSK | 1 | $22 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $9 |
| Biosense Webster, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,943 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 39 | $381 |
| Losartan Potassium | 13 | $120 |
| Atorvastatin Calcium | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dallas
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Martha LibertyDallas$28K
- Rachael SchneiderDallas$20K
- Peter TriporoDallas$15K
- Mario PadillaDallas$13K
- Toni SmithDallas$10K
- Christie MorrisonSan Antonio$225K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.